Vermont Woman Files Xarelto Lawsuit Alleging Father Died From Brain Bleed Linked To Drug

June 11, 2016 – – TheProductLawyers.com reports on Xarelto a new-generation blood-thinning drug that has been alleged to cause spontaneous instances of uncontrollable bleeding resulting in long-term injuries or death in many cases. Since its release on the market it fast became the focus of a large number of lawsuits totaling more than 3,000 and have all been levied against Bayer AG and Janssen Pharmaceuticals, the makers of the drug. The latter is a subsidiary of corporate giant Johnson and Johnson.

One such case involves a woman who filed a lawsuit in a Vermont federal court on behalf of her deceased father who died suddenly of a parenchymal hemorrhage, more commonly known as a brain bleed. He was taking Xarelto at the time of his death and doctors were unable to save him since the drug prevented them from clotting his blood.

It should be noted that of the 3,000 Xarelto cases, 2,800 are federal court suits from all across the country that were consolidated by the U.S. Judicial Panel on Multidistrict Litigation (JPML). The multidistrict litigation (MDL 2592) is being overseen by a court in Louisiana. The reason such a large number of cases have been able to be consolidated is because they all bear strikingly similar allegations and have been filed against the same defendants, Janssen and Bayer. Such a step to consolidate these cases together will serve to hasten the litigation process, thus saving time and money for all involved in bringing the cases to trial. Additionally, consolidation will help to prevent many different rulings by numerous judges.

The trials of those cases included in MDL 2592 are progressing forward with the selection of a number of bellwether trials having occurred. An additional 550 having been lumped together in a mass group tort in Philadelphia, Pennsylvania by the state’s Court of Common Pleas.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010564